Millenco reports 4% stake in Medivation

By Jennifer Chiou

New York, March 13 - Medivation, Inc. investors led by Millenco LLC sold and purchased shares of the company's stock between Jan. 14 and March 12 to lower its stake in the company to less than 5%, according to a schedule 13D filing with the Securities and Exchange Commission.

The investor beneficially owns 1.17 million shares, or 4%, of the San Francisco biopharmaceutical company's outstanding stock.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.